Article | June 22, 2016

The Impact Of Waste On The Cost Of Quality In The Pharmaceutical Industry

Source: Parenteral Drug Association (PDA)

By Robert G. Kieffer, PhD, RGK Consulting

Waste has a significant impact on the cost of quality (COQ)—or more exactly, the cost of poor quality—in the pharmaceutical industry. As a consultant with many years of experience in the industry, I’ve observed the negative effects of waste at many companies, and I want to identify activities that can be defined as “wasteful.”

When I refer to waste, I refer to activities within a process that are not value-added nor performed correctly the first time, and/or process outputs that are not desired by the customer. Ultimately, it is the customers, our patients, who pay for this waste, which also negatively impacts our employees’ morale and motivation.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Parenteral Drug Association (PDA)